Emalex Biosciences
PrivateLast Round
Series D
Nov 3, 2022
Total Funding Raised
$300M
Momentum Score
25 /100
Company Overview
Emalex Biosciences is a biopharmaceutical company focused on developing innovative drugs aimed at diagnosing and treating central nervous system disorders and rare neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emalex Biosciences Comps
Public and private peers based on sector, stage, and business model.
Emalex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 3, 2022 | ||||
| Series C | Mar 23, 2021 | ||||
| Debt | Jun 3, 2020 |
Emalex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series D |
| Fidelity Management & Research Company | Series C, Series D |
| Paragon Biosciences | Series D, Series C |
| Valor Equity Partners | Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 84% MoM.
- Apr 29, 2026
Developing a treatment for Tourette syndrome.
Emalex Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Emalex Biosciences's valuation, stock price, and market status.
